Determines prevalence of non-fermenting gram-negative bacilli infections and resistance patterns, suggesting treatment strategies.
BACKGROUND: Non-fermenting Gram-negative bacilli (NFGNB) are emerging as a significant cause of bloodstream infections (BSIs), a major concern of morbidity and mortality worldwide. The high intrinsic resistance of NFGNB to antimicrobial compounds makes treatment of BSI difficult and expensive. AIMS: This study aimed to determine the prevalence of NFGNB and the antimicrobial susceptibility pattern of the isolates. METHODOLOGY: A total of 1230 blood culture samples were received in the department of microbiology during the study period of 3 months, which were processed by standard microbiological procedures. Antimicrobial susceptibility tests were performed using Clinical and Laboratory Standards Institute (CLSI) guidelines. RESULTS: Out of 255 (20.73%) positive blood culture samples, 105 (8.5%) Gram-negative bacilli were isolated, of which 41 (3.33%) NFGNB were identified. The most common isolate identified is Pseudomonas aeruginosa (21), followed by Acinetobacter spp. (20). A higher percentage of antibiotic resistance was seen for Acinetobacte r spp. and even higher antibiotics like ceftazidime (87.5%) and gentamicin (92.5%). CONCLUSION: This study will help us start empirical treatment and implement proper hospital infection control measures.
No takes yet. Share an insight, caveat, or question.
Poddar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: